To confirm the direct involvement of the RARα signalling pathway in the modulation of ATPR‐inhibited LDHB expression, AML cells were treated with ATPR in the absence or in the presence of the RARα‐selective antagonist Ro 41‐5253. This evidence concerns the gene RARA and acute myeloid leukemia.